Displaying 1081 - 1100 of 1551
FTC Charges Chicago-Area Doctor Groups With Price Fixing
Advocate Health Partners, et al., In the Matter of
The final consent order settles charges that the conduct of several organizations representing more than 2,900 independent Chicago-area physicians for agreeing to fix prices and for refusing to deal with certain health plans except on collectively determined terms. The order will prohibit the respondents from engaging in such anticompetitive conduct in the future.
FTC Challenges Terms of Johnson & Johnsons Proposed Acquisition of Pfizers Consumer Healthcare Business To Protect Competition
Watson Pharmaceuticals, Inc. and Andrx Corporation., In the Matter of
A consent order settled charges that Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, would have likely led to competitive problems in the markets for 13 generic drug products. Watson was required to end its marketing agreements with Interpham Holdings, divest Andrx’s right to develop, make, and market generic extended release tablets that correct the effects of type 2 diabetes, and divest Andrx’s rights and assets related to the developing and marketing of 11 generic oral contraceptives.
There is a related federal proceeding and two related administrative proceedings:
FTC Approves Final Consent Order in Barr/Pliva Matter
Barr Pharmaceuticals, Inc., In the Matter of
The consent order settles charges that Barr Pharmaceutical, Inc.’s proposed acquisition of Pliva d.d for approximately $2.5 billion would have eliminated current or future competition between Barr and Pliva in certain markets for generic pharmaceuticals treating depression, high blood pressure and ruptured blood vessels, and in the market for organ preservation solutions. In settling the Commission’s charges, Barr is required to sell its generic antidepressant trazodone and its generic blood pressure medication triamterene/HCTZ. Barr also is required to divest either Pliva’s or Barr’s generic nimodipine for use in treating ruptured blood vessels in the brain. Finally, Barr is required to divest Pliva’s branded organ preservation solution Custodial.
FTC Challenges Terms of Watson Pharmaceuticals Acquisition of Andrx
Court Enters Final Order Settling FTCs Charges Against Warner Chilcott
Consumers Win as FTC Action Results in Generic Ovcon Launch
FTC Challenges Barrs Proposed Acquisition of Pliva
FTC Charges That Thermo Electrons Acquisition of Fisher Scientific Would Lessen Competition in U.S. Market for Centrifugal Vacuum Evaporators
Staff Submits Comments on Pharmacy Benefit Managers to Virginia House of Delegates; Commission Approves Issuance of Strategic Plan for Fiscal Years 2006-2011; FTC Approves Final Consent Order in Matter of New Century Health Quality Alliance, Inc.
New Century Health Quality Alliance, Inc., Prime Care of Northeast Kansas, LLC, et al., In the Matter of
The Commission approved a final consent order settling Commission charges alleging that two independent practice associations (IPAs) and 18 member physician practices in the Kansas City, MO area, refused to deal with health care plans, except on collectively agreed-upon prices and other terms.
Prepared Statement of the Federal Trade Commission On Health Care Competition
Prepared Statement of the Federal Trade Commission On Health Care Competition
FTC Testifies on Competition in Group Health Care
Puerto Rico Association of Endodontists, Corp., In the Matter of
Displaying 1081 - 1100 of 1551